SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999.
Great Wolf Resorts (Nasdaq: WOLF) $2.31, Today reported results today for the third quarter ended September 30, 2010. For the third quarter ended September 30, 2010, the Company reported significant improvement year over year as it reduced its net loss to $(1.0) million, or $(0.03) per diluted share, compared to a net loss $(36.9) million, or $(1.18) per diluted share for the same period a year earlier. The improvement was primarily driven by higher year over year revenues in the 2010 quarter as well as the effects of certain charges in the 2009 quarter. The 2009 results included a non-cash impairment charge of $24.0 million related to the Company’s Blue Harbor Resort & Conference Center in Sheboygan, Wisconsin.
“Demand was solid in our seasonally important third quarter as consumers continue to enjoy a Great Wolf getaway,” said Kim Schaefer, chief executive officer. “We were able to improve RevPAR and total revenue per occupied room as a result of higher average daily rates and an increase in guest spending on the wide range of amenities we offer at our resorts. As the consumer recovery is progressing slowly, we continue to work to enhance our brand and our operations. The operating efficiencies we have been implementing are starting to be evident in our results and we anticipate further leveraging these improvements as the economy improves.”
What They Do: Great Wolf Resorts is North America’s largest family of indoor waterpark resorts.
Rome Research Corporation a subsidiary of PAR Technology Corporation (NYSE: PTC), Today announced it was awarded a $12.3 million contract to operate and maintain the Robert E. Kamosa Transmitting Station Facilities which are radio transmitting facilities located on Tinian and Saipan. The contract, awarded by the Broadcasting Board of Governors, an agency of the United States government, has a performance period of 5 years. RRC provides broadcast services, operations and maintenance of high-frequency radio transceiver equipment, maintenance of the satellite communication system, and other related services.
“We are pleased that the BBG selected Rome Research to support its radio transmitting operations at Tinian and Saipan. In addition to RRC’s extensive knowledge in performing these services, our contract proposal exceeded the customer’s expectations and provided the basis to elevate RRC for the contract award decision,” commented Steve Lynch, President of PAR’s Government Operations. “We look forward to our continuing partnership with the BBG in support of its on-going mission.”
What They Do: PAR Technology Corporation creates and markets products that help hospitality operators around the world to better manage money, materials, people and the guest experience. PAR has provided hardware, software and services to the world's largest restaurant chains and their franchisees for almost 30 years.
GTx, Inc. (Nasdaq: GTXI) $2.80. Today announced that the company has been awarded approximately $1.2 million by the United States Government under the Qualifying Therapeutic Discovery Project Program (QTDP), a $1 billion fund established under HR: 3590 – Patient Protection and Affordable Care Act. The QTDP provides a tax credit or cash grant to companies with 250 or fewer employees to cover up to 50 percent of qualified investments in projects aimed at creating new therapies, reducing long-term health care costs, or significantly advancing the goal of curing cancer within the next 30 years. The grant to GTx comprises separate payments of $244,000 for each of five cancer and cancer supportive care research and development programs.
“We are pleased to receive this recognition and these funds which will help GTx advance our pipeline of clinical and preclinical product candidates,” said Mitchell S. Steiner, MD, CEO of GTx.
What They Do: GTx, Inc., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment and prevention of cancer, the treatment of side effects of anticancer therapy, cancer supportive care, and other serious medical conditions.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit SmallCapReview.com.
